Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.

about

Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity.Effects of single and combined gabapentin use in elevated plus maze and forced swimming tests.

P2860

Q33578200-8352EEA2-6128-4E91-9F21-047295F26B8E Q44255920-259B2C52-8959-4CC2-B9C7-56944CC273B0

P2860

Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.

Item

http://www.wikidata.org/entity/Q38175904

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacoeconomic outcomes for ...... sy from a Spanish perspective.

@en

type

Item

label

Pharmacoeconomic outcomes for ...... sy from a Spanish perspective.

@en

prefLabel

Pharmacoeconomic outcomes for ...... sy from a Spanish perspective.

@en

P1476

Pharmacoeconomic outcomes for ...... psy from a Spanish perspective

@en

P2093

Antoni Sicras-Mainar

http://www.w3.org/2001/XMLSchema#string

Concepción Pérez

http://www.w3.org/2001/XMLSchema#string

Josep Darbà

http://www.w3.org/2001/XMLSchema#string

Lisette Kaskens

http://www.w3.org/2001/XMLSchema#string

Ruth Navarro-Artieda

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

A cost-consequence analysis of pregabalin versus usual care in the symptomatic treatment of refractory low back pain: sub-analysis of observational trial data from orthopaedic surgery and rehabilitation clinics.

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective

A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.

Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings.

The evidence for pharmacological treatment of neuropathic pain.

The epidemiology of generalized anxiety disorder in Europe.

P2888

s12325-013-0088-2

P304

1-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-013-0088-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Enric Álvarez Martínez

P577

2014-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039668543

http://www.w3.org/2001/XMLSchema#string

P698

24390901

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.

about

P2860

P2860

Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921